The Grace Kelly Childhood Cancer Trust are proud to be able to announce that we have awarded £99,932.48 to fund a vital three year research project into rare, aggressive cancers of childhood.
The project that has received the award is entitled:
“Recapitulating the post-surgical brain microenvironment of atypical rhabdoid teratoid tumours to identify proteins for targeted therapy,” and is led by research scientist Dr Ruman Rahman at Nottingham University.
This project primarily looks at certain rare cancers of childhood called atypical rhabdoid teratoid tumours. This is an exciting project with very real potential of making significant progress in the treatment of this cancer type. Our Research Advisory Panel believed that the outcomes from this project could then potentially be applied to other tumour types too.
The funding for this project has been provided by our Grace Kelly Childhood Cancer Trust fundraisers and our wonderful special named funds who have done the most incredible fundraising activities to help make this possible.
We would like to say a special thank you to each of the following named funds for their hard work and dedication: Inspirational Issy, Sophie’s Wish, Molly’s Way, Ella’s Fund, Edward’s Fund Esther’s Smile, Evelyn’s Fund, Captain Chaos Challenges, Ada Princess Fund and Connall’s Superhero Fund for your wonderful fundraising. Without your fundraising efforts, this simply would not have been possible.
Dr Jen Kelly, CEO said:
“We are proud to award this significant grant funding to such a worthwhile project. One of our aims at the Trust is to continually strive for better and kinder treatments for children with cancer. To achieve this, making scientific advances through funding appropriate research is vital. Rhabdoid tumours and other rare sarcomas have very poor survival rates in children, and we are working tirelessly to change this. I would like to personally thank all members of our Research Advisory Panel, chaired by Professor Bernadette Brennan and our external written reviewers for their time and expertise.“
Dr Ruman Rahman, project lead, Nottingham University said:
"We are delighted to be awarded this project grant, which will enable us to identify proteins on the surface of cancer cells, representing new therapy targets to better treat childhood atypical teratoid/rhabdoid tumours."
The Grace Kelly Childhood Cancer Trust are accredited members of the AMRC (Association of Medical Research Charities) after having been on the way that it funds its research. AMRC membership shows that we fund our research using the research gold standard processes of open project funding rounds, external written scientific reviews by scientists who are experts in their field and then scored and ranked by our expert led Research Advisory Panel.
This means that we can be sure we fund the projects that could make the biggest possible difference to children with cancer, both now and in the future. To find out more about how we award research funding, and our membership as an accredited member of the AMRC, please see here.
For further information about our special named funds, and the wonderful children that they are in honour of, please see here.
For more information please contact:
Dr Jen Kelly - CEO
T: 01905 885777